Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

PharmaCyte Biotech Inc
NASDAQ:PMCB

Watchlist Manager
PharmaCyte Biotech Inc Logo
PharmaCyte Biotech Inc
NASDAQ:PMCB
Watchlist
Price: 0.6981 USD -11.07% Market Closed
Market Cap: $4.7m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
-2%
5Y
-62%
10Y
0%
Investing Cash Flow
+
3Y
-
5Y
-
10Y
-
Financing Cash Flow
+
3Y
-
5Y
-68%
10Y
-61%

Cash Flow Statement
PharmaCyte Biotech Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Apr-2005 Jul-2005 Oct-2005 Jan-2006 Apr-2006 Jul-2006 Oct-2006 Jan-2007 Apr-2007 Jul-2007 Oct-2007 Jan-2008 Apr-2008 Jul-2008 Oct-2008 Jan-2009 Apr-2009 Jul-2009 Oct-2009 Jan-2010 Apr-2010 Jul-2010 Oct-2010 Jan-2011 Apr-2011 Jul-2011 Oct-2011 Jan-2012 Apr-2012 Jul-2012 Oct-2012 Jan-2013 Apr-2013 Jul-2013 Oct-2013 Jan-2014 Apr-2014 Jul-2014 Oct-2014 Jan-2015 Apr-2015 Jul-2015 Oct-2015 Jan-2016 Apr-2016 Jul-2016 Oct-2016 Jan-2017 Apr-2017 Jul-2017 Oct-2017 Jan-2018 Apr-2018 Jul-2018 Oct-2018 Jan-2019 Apr-2019 Jul-2019 Oct-2019 Jan-2020 Apr-2020 Jul-2020 Oct-2020 Jan-2021 Apr-2021 Jul-2021 Oct-2021 Jan-2022 Apr-2022 Jul-2022 Oct-2022 Jan-2023 Apr-2023 Jul-2023 Oct-2023 Jan-2024 Apr-2024 Jul-2024 Oct-2024 Jan-2025 Apr-2025 Jul-2025 Oct-2025
Operating Cash Flow
Net Income
(4)
(5)
(6)
(6)
(9)
(9)
(8)
(8)
(4)
(3)
(3)
(3)
(4)
(3)
(3)
(3)
(7)
(7)
(7)
(8)
(6)
(5)
(5)
(3)
(1)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(6)
(11)
(11)
(27)
(24)
(23)
(24)
(10)
(10)
(7)
(8)
(6)
(6)
(5)
(4)
(4)
(5)
(6)
(7)
(7)
(6)
(6)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(3)
(3)
(4)
(4)
(4)
(4)
(4)
(5)
(6)
(6)
(4)
(6)
(1)
(1)
0
27
23
20
31
(1)
(7)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
2
2
14
13
17
18
6
0
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
0
1
1
1
0
1
1
0
0
0
0
1
1
1
1
1
1
1
1
1
0
1
0
Other Non-Cash Items
1
2
4
5
13
12
11
10
2
1
2
3
5
6
6
5
1
1
1
2
4
4
4
2
1
2
2
2
1
1
1
1
1
5
10
11
26
22
19
19
4
4
2
2
3
2
2
1
1
1
2
2
2
2
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
1
1
4
(1)
(1)
(3)
(30)
(25)
(23)
(35)
(3)
2
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
0
1
0
0
(4)
(4)
(3)
(2)
1
1
1
(1)
(3)
(3)
(4)
(3)
5
5
5
5
1
1
1
1
0
0
0
0
0
0
0
1
0
0
0
(1)
(0)
(0)
(0)
1
2
1
1
1
(1)
(1)
(0)
(0)
(0)
0
0
0
(0)
(0)
0
(0)
0
(0)
(0)
0
0
1
(0)
(0)
(0)
(1)
(1)
(0)
0
1
1
0
(0)
(0)
(1)
0
0
(0)
(0)
0
1
(0)
0
Cash from Operating Activities
(3)
N/A
(3)
+9%
(2)
+40%
(1)
+14%
(1)
+18%
(1)
+24%
(1)
-5%
(0)
+95%
(0)
-678%
(1)
-93%
(1)
-26%
(2)
-105%
(1)
+31%
(1)
+18%
(1)
+25%
(1)
+9%
(1)
-79%
(2)
-32%
(2)
-9%
(2)
+9%
(1)
+38%
(0)
+55%
(0)
+63%
(0)
+17%
(0)
-69%
(0)
-44%
(0)
-15%
(0)
+9%
(0)
+26%
(0)
+13%
(0)
-15%
(0)
-16%
(0)
-30%
(0)
-19%
(1)
-26%
(1)
-29%
(2)
-104%
(2)
-41%
(3)
-53%
(4)
-17%
(5)
-17%
(5)
-6%
(5)
+6%
(5)
-4%
(4)
+8%
(4)
+4%
(4)
+8%
(4)
+2%
(3)
+11%
(3)
-1%
(4)
-26%
(5)
-6%
(5)
-13%
(5)
+6%
(4)
+14%
(4)
+12%
(3)
+20%
(3)
-5%
(3)
+11%
(2)
+12%
(2)
+1%
(2)
+9%
(3)
-31%
(3)
-8%
(3)
-10%
(4)
-21%
(4)
-3%
(4)
+7%
(4)
-7%
(4)
+4%
(4)
-12%
(5)
-5%
(4)
+19%
(2)
+38%
(2)
-4%
(2)
+15%
(2)
-2%
(3)
-33%
(2)
+32%
(2)
-17%
(3)
-31%
(5)
-54%
(5)
+2%
Investing Cash Flow
Capital Expenditures
0
0
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
0
(0)
(0)
0
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Items
(0)
0
1
0
0
0
0
0
0
0
(0)
(0)
0
0
0
0
(0)
0
0
0
0
0
0
0
0
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(3)
(4)
(2)
(1)
(2)
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(5)
(5)
(12)
(12)
(7)
(7)
0
(3)
Cash from Investing Activities
(0)
N/A
0
N/A
1
+12%
0
-38%
0
-50%
(0)
N/A
(0)
+43%
(1)
-29 350%
(1)
+41%
(1)
-1%
(1)
-17%
0
N/A
(0)
N/A
(0)
+60%
0
N/A
0
-79%
(0)
N/A
0
N/A
0
N/A
0
+88%
0
+133%
0
-34%
0
N/A
0
N/A
0
N/A
(0)
N/A
(1)
-75%
(1)
-21%
(1)
-28%
(1)
+14%
(1)
+15%
(1)
-6%
(1)
+3%
(2)
-211%
(3)
-42%
(3)
+6%
(4)
-31%
(2)
+44%
(1)
+37%
(2)
-20%
0
N/A
0
N/A
0
N/A
1
+100%
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(5)
N/A
(5)
N/A
(12)
-140%
(12)
N/A
(7)
+42%
(7)
N/A
0
N/A
(3)
N/A
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
1
1
1
2
1
1
1
1
1
1
1
0
0
0
0
1
1
1
0
0
0
1
1
1
0
(0)
(0)
0
1
3
4
4
9
7
6
6
4
5
5
6
4
4
3
3
5
5
5
4
3
2
2
3
2
2
2
2
3
4
6
6
5
3
87
87
87
85
(5)
(9)
(14)
(3)
(1)
(4)
(11)
(29)
(39)
(36)
(25)
(15)
2
Net Issuance of Debt
3
0
1
1
1
1
1
0
0
0
0
0
0
0
0
(0)
0
0
0
(0)
(0)
(0)
(0)
(0)
0
0
0
0
1
1
1
1
0
(0)
0
0
0
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(2)
0
0
0
0
0
0
0
0
(0)
Cash from Financing Activities
3
N/A
0
-84%
1
+54%
1
+64%
2
+59%
2
-9%
2
+4%
2
-9%
1
-36%
1
+35%
1
-20%
2
+35%
2
+2%
1
-23%
1
-3%
0
-61%
0
-39%
0
-10%
0
+88%
1
+18%
0
-48%
0
+12%
0
-68%
0
-14%
0
+201%
1
+162%
1
+30%
1
+11%
1
+2%
1
-16%
1
-2%
1
+8%
1
+26%
3
+119%
4
+44%
4
+12%
9
+98%
7
-20%
5
-22%
6
+3%
4
-34%
5
+33%
5
+12%
6
+13%
4
-42%
4
+1%
3
-15%
3
+9%
5
+45%
5
+9%
5
+2%
4
-34%
3
-25%
2
-13%
2
N/A
3
+20%
2
-16%
2
-35%
2
+20%
2
-1%
3
+50%
4
+45%
6
+63%
6
-8%
5
-22%
3
-39%
87
+3 002%
87
+0%
87
0%
85
-2%
(6)
N/A
(9)
-68%
(14)
-46%
(5)
+62%
(1)
+80%
(4)
-309%
(11)
-148%
(27)
-154%
(39)
-42%
(36)
+8%
(25)
+30%
(15)
+41%
2
N/A
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
0
0
(0)
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
(0)
(0)
Net Change in Cash
(0)
N/A
(2)
-3 084%
(0)
+83%
0
N/A
1
+341%
1
-8%
1
+4%
0
-53%
0
-89%
0
+96%
(0)
N/A
0
N/A
0
+43%
0
-37%
1
+130%
(0)
N/A
(1)
-435%
(1)
-42%
(1)
+7%
(1)
+21%
(1)
+37%
(0)
+91%
(0)
+83%
0
N/A
0
+1 624%
0
+65%
0
-82%
0
+143%
(0)
N/A
(0)
-47%
0
N/A
(0)
N/A
0
N/A
0
+1%
0
+106%
1
+122%
3
+311%
3
-21%
1
-72%
0
-88%
(1)
N/A
0
N/A
1
+8 602%
2
+65%
(1)
N/A
(1)
+27%
(1)
-33%
(0)
+47%
2
N/A
2
+26%
1
-42%
(1)
N/A
(2)
-152%
(2)
-2%
(2)
+27%
(1)
+54%
(1)
+32%
(2)
-173%
(1)
+43%
(1)
+35%
0
N/A
2
+384%
4
+100%
3
-20%
1
-56%
(1)
N/A
83
N/A
84
+0%
83
0%
81
-2%
(10)
N/A
(14)
-40%
(17)
-24%
(8)
+56%
(4)
+53%
(11)
-223%
(18)
-56%
(42)
-135%
(53)
-25%
(45)
+15%
(35)
+22%
(19)
+44%
(5)
+72%
Free Cash Flow
Free Cash Flow
(3)
N/A
(3)
+9%
(2)
+39%
(1)
+14%
(1)
+18%
(1)
+24%
(1)
-4%
(1)
-43%
(1)
+14%
(1)
-31%
(2)
-15%
(1)
+19%
(1)
+5%
(1)
+18%
(1)
+28%
(1)
+8%
(1)
-80%
(2)
-35%
(2)
-9%
(2)
+8%
(1)
+40%
(0)
+60%
(0)
+70%
(0)
+23%
(0)
-155%
(0)
-44%
(0)
-15%
(0)
+9%
(0)
+26%
(0)
+13%
(0)
-15%
(0)
-16%
(0)
-30%
(0)
-19%
(1)
-26%
(1)
-29%
(2)
-104%
(2)
-41%
(3)
-53%
(4)
-17%
(5)
-17%
(5)
-6%
(5)
+6%
(5)
-4%
(4)
+8%
(4)
+4%
(4)
+8%
(4)
+2%
(3)
+11%
(3)
-1%
(4)
-26%
(5)
-6%
(5)
-13%
(5)
+6%
(4)
+14%
(4)
+12%
(3)
+20%
(3)
-5%
(3)
+11%
(2)
+12%
(2)
+1%
(2)
+9%
(3)
-31%
(3)
-8%
(3)
-10%
(4)
-21%
(4)
-3%
(4)
+7%
(4)
-7%
(4)
+4%
(4)
-12%
(5)
-5%
(4)
+19%
(2)
+38%
(2)
-4%
(2)
+15%
(2)
-2%
(3)
-33%
(2)
+32%
(2)
-17%
(3)
-31%
(5)
-54%
(5)
+2%

See Also

Summary
PMCB intrinsic value, competitors valuation, and company profile.
DCF Valuation
PMCB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PMCB stock valuation using valuation multiples.
Wall Street Estimates
PMCB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PMCB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 315,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.